Top Alzheimer’s researchers report near-100 drugs in key trials, and hopes for a breakthrough

The search for an Alzheimer’ s disease cure has been dogged by pharmaceutical failures, but a network of the world’ s top dementia scientists released a report on Sunday saying that the number of drugs making it to phase two and phase three of clinical trials encourages them to believe that a blockbuster may be among compounds in the current development pipeline.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.